Skip to content

Clinical trials

Cross Infection trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cross Infection Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20151
20201
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Third Hospital2
Capital Medical University1
Children's Hospital of Fudan University1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai Zhongshan Hospital1
Southeast University, China1
The First Hospital of Qinhuangdao1
The Hong Kong Polytechnic University1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cross Infection10
Communicable Diseases2
Abdominal Abscess1
Community-Acquired Infections1
Influenza, Human1
Peritonitis1
Pneumonia, Ventilator-Associated1

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.